USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 157 filers reported holding USANA HEALTH SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,563 | -9.8% | 1,494 | -3.0% | 0.00% | – |
| Q2 2023 | $97,082 | -3.2% | 1,540 | -3.4% | 0.00% | – |
| Q1 2023 | $100,263 | +3.4% | 1,594 | -12.9% | 0.00% | – |
| Q4 2022 | $97,000 | +86.5% | 1,830 | +98.9% | 0.00% | – |
| Q3 2022 | $52,000 | -60.9% | 920 | -50.1% | 0.00% | – |
| Q2 2022 | $133,000 | -5.7% | 1,843 | +3.9% | 0.00% | – |
| Q1 2022 | $141,000 | -23.8% | 1,774 | -3.0% | 0.00% | – |
| Q4 2021 | $185,000 | -11.1% | 1,828 | -18.9% | 0.00% | – |
| Q3 2021 | $208,000 | -11.5% | 2,255 | -1.6% | 0.00% | -100.0% |
| Q2 2021 | $235,000 | +2.2% | 2,291 | -1.7% | 0.00% | 0.0% |
| Q1 2021 | $230,000 | +167.4% | 2,331 | +110.8% | 0.00% | – |
| Q4 2020 | $86,000 | -44.2% | 1,106 | -47.1% | 0.00% | – |
| Q3 2020 | $154,000 | +90.1% | 2,092 | +90.5% | 0.00% | – |
| Q2 2020 | $81,000 | +30.6% | 1,098 | +3.7% | 0.00% | – |
| Q1 2020 | $62,000 | – | 1,059 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |